These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. [Catatonic syndrome and neuroleptic malignant syndrome]. Ruzikowska A Psychiatr Pol; 1999; 33(3):415-25. PubMed ID: 10786241 [TBL] [Abstract][Full Text] [Related]
9. Neuroleptic malignant syndrome: a review and report of six cases. Kasantikul D; Kanchanatawan B J Med Assoc Thai; 2006 Dec; 89(12):2155-60. PubMed ID: 17214072 [TBL] [Abstract][Full Text] [Related]
11. [What do we know today about neuroleptic malignant syndrome?]. Nyquist OG Tidsskr Nor Laegeforen; 1996 Oct; 116(24):2879-82. PubMed ID: 8975402 [TBL] [Abstract][Full Text] [Related]
12. Neuroleptic malignant syndrome: need for early diagnosis and therapy. Khan HM; Syed NA; Sheerani M; Khcalani B; Kamal A; Wasay M J Ayub Med Coll Abbottabad; 2006; 18(1):17-21. PubMed ID: 16773963 [TBL] [Abstract][Full Text] [Related]
13. Neuroleptic malignant syndrome: a review of the literature. Pearlman CA J Clin Psychopharmacol; 1986 Oct; 6(5):257-73. PubMed ID: 2877012 [TBL] [Abstract][Full Text] [Related]
14. [Clinical differentiation between lethal catatonia and neuroleptic malignant syndrome: a case report]. Terlikowska M; Marzański M Psychiatr Pol; 1995; 29(3):343-8. PubMed ID: 7652087 [TBL] [Abstract][Full Text] [Related]
15. [The neuroleptic malignant syndrome (NMS). A report of a clinical case with a protracted and recurrent course. A review of the literature]. Marelli A; Bodini P; Dizioli P; Chiodelli G; Guarneri M; Boldori L Minerva Med; 1996; 87(1-2):45-51. PubMed ID: 8610025 [TBL] [Abstract][Full Text] [Related]
16. Neuroleptic malignant syndrome induced by ziprasidone on the second day of treatment. Ozen ME; Yumru M; Savas HA; Cansel N; Herken H World J Biol Psychiatry; 2007; 8(1):42-4. PubMed ID: 17366349 [TBL] [Abstract][Full Text] [Related]
17. Neuroleptic malignant syndrome in the elderly. Leipsic JS; Abraham HD; Halperin P J Geriatr Psychiatry Neurol; 1995 Jan; 8(1):28-31. PubMed ID: 7710643 [TBL] [Abstract][Full Text] [Related]
18. Catatonic variants, hyperthermic extrapyramidal reactions, and subtypes of neuroleptic malignant syndrome. Lee JW Ann Clin Psychiatry; 2007; 19(1):9-16. PubMed ID: 17453656 [TBL] [Abstract][Full Text] [Related]
19. The evaluation and management of patients with neuroleptic malignant syndrome. Bhanushali MJ; Tuite PJ Neurol Clin; 2004 May; 22(2):389-411. PubMed ID: 15062519 [TBL] [Abstract][Full Text] [Related]
20. ECT as a treatment alternative for patients with symptoms of neuroleptic malignant syndrome. Addonizio G; Susman VL J Clin Psychiatry; 1987 Mar; 48(3):102-5. PubMed ID: 2880837 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]